← Back to Clinical Trials
Recruiting NCT06953921
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
Trial Parameters
Condition Hepatic Encephalopathy
Sponsor Sohag University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-03-12
Completion 2025-09-12
Brief Summary
assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.
Eligibility Criteria
Inclusion Criteria: * patients aged \>18 years. * Confirmed chronic liver disease (by imaging , * liver function tests , and clinical history). * Diagnosed with hepatic encephalopathy based on clinical criteria. * Patients able to provide informed consent. Exclusion Criteria: * Patients age less than 18 years old * Acute liver failure. * Chronic renal failure on dialysis. * Pregnant women. * Patients with active malignancy.
Related Trials
NCT06808074
A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients
View Trial →
NCT06368895
Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment
View Trial →
NCT06538077
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
View Trial →